Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
67.2 USD | -0.21% | +0.18% | +7.99% |
05-16 | Axonics Implant Approved in Australia to Treat Overactive Bladders | MT |
05-16 | Axonics, Inc. Receives Regulatory Approval for Recharge-Free SNM System in Australia | CI |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registrationEPS Revisions
1st Jan change | Capi. | |
---|---|---|
+7.99% | 3.43B | |
+15.20% | 131B | |
-11.58% | 7.71B | |
+41.65% | 5.67B | |
-18.05% | 4.95B | |
-19.96% | 2.46B | |
-15.76% | 1.97B | |
-16.68% | 1.85B | |
-32.15% | 1.57B | |
-15.83% | 1.08B |
- Stock Market
- Equities
- AXNX Stock
- News Axonics, Inc.
- Axonics Implant Approved in Australia to Treat Overactive Bladders